Ameritas Investment Partners’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $88.5K | Hold |
2,677
| – | – | ﹤0.01% | 1758 |
|
|
2025
Q4 | $124K | Hold |
2,677
| – | – | ﹤0.01% | 1568 |
|
|
2025
Q3 | $93.7K | Sell |
2,677
-742
| -22% | -$25.8K | ﹤0.01% | 1732 |
|
|
2025
Q2 | $101K | Hold |
3,419
| – | – | ﹤0.01% | 1754 |
|
|
2025
Q1 | $102K | Hold |
3,419
| – | – | ﹤0.01% | 1686 |
|
|
2024
Q4 | $98K | Hold |
3,419
| – | – | ﹤0.01% | 1790 |
|
|
2024
Q3 | $132K | Hold |
3,419
| – | – | ﹤0.01% | 1612 |
|
|
2024
Q2 | $110K | Hold |
3,419
| – | – | ﹤0.01% | 1661 |
|
|
2024
Q1 | $133K | Hold |
3,419
| – | – | ﹤0.01% | 1555 |
|
|
2023
Q4 | $105K | Hold |
3,419
| – | – | ﹤0.01% | 1700 |
|
|
2023
Q3 | $76.4K | Buy |
3,419
+602
| +21% | +$13.7K | ﹤0.01% | 1838 |
|
|
2023
Q2 | $60.5K | Hold |
2,817
| – | – | ﹤0.01% | 1926 |
|
|
2023
Q1 | $67.6K | Hold |
2,817
| – | – | ﹤0.01% | 1791 |
|
|
2022
Q4 | $79.5K | Hold |
2,817
| – | – | ﹤0.01% | 1748 |
|
|
2022
Q3 | $45K | Hold |
2,817
| – | – | ﹤0.01% | 2050 |
|
|
2022
Q2 | $49K | Hold |
2,817
| – | – | ﹤0.01% | 1992 |
|
|
2022
Q1 | $57K | Hold |
2,817
| – | – | ﹤0.01% | 1989 |
|
|
2021
Q4 | $53K | Hold |
2,817
| – | – | ﹤0.01% | 2092 |
|
|
2021
Q3 | $56K | Hold |
2,817
| – | – | ﹤0.01% | 2079 |
|
|
2021
Q2 | $67K | Hold |
2,817
| – | – | ﹤0.01% | 1983 |
|
|
2021
Q1 | $67K | Hold |
2,817
| – | – | ﹤0.01% | 1904 |
|
|
2020
Q4 | $56K | Hold |
2,817
| – | – | ﹤0.01% | 1911 |
|
|
2020
Q3 | $59K | Hold |
2,817
| – | – | ﹤0.01% | 1734 |
|
|
2020
Q2 | $49K | Hold |
2,817
| – | – | ﹤0.01% | 1832 |
|
|
2020
Q1 | $46K | Hold |
2,817
| – | – | ﹤0.01% | 1704 |
|
|
2019
Q4 | $58K | Buy |
2,817
+484
| +21% | +$8.07K | ﹤0.01% | 1829 |
|
|
2019
Q3 | $27K | Hold |
2,333
| – | – | ﹤0.01% | 2223 |
|
|
2019
Q2 | $31K | Hold |
2,333
| – | – | ﹤0.01% | 2182 |
|
|
2019
Q1 | $35K | Hold |
2,333
| – | – | ﹤0.01% | 2076 |
|
|
2018
Q4 | $40K | Hold |
2,333
| – | – | ﹤0.01% | 1937 |
|
|
2018
Q3 | $34K | Hold |
2,333
| – | – | ﹤0.01% | 2199 |
|
|
2018
Q2 | $56K | Buy |
2,333
+343
| +17% | +$8.43K | ﹤0.01% | 1908 |
|
|
2018
Q1 | $51K | Hold |
1,990
| – | – | ﹤0.01% | 1910 |
|
|
2017
Q4 | $37K | Hold |
1,990
| – | – | ﹤0.01% | 2089 |
|
|
2017
Q3 | $19K | Hold |
1,990
| – | – | ﹤0.01% | 2443 |
|
|
2017
Q2 | $25K | Buy |
1,990
+935
| +89% | +$9.24K | ﹤0.01% | 2334 |
|
|
2017
Q1 | $11K | Buy |
+1,055
| New | +$15.7K | ﹤0.01% | 2654 |
|
Other funds holding COLL
EAM
VCM
Ameritas Investment Partners's COLL Position: Q1 2026 in Review
Ameritas Investment Partners held its Collegium Pharmaceutical (COLL) position steady in Q1 2026 at 2,677 shares worth $88.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1758.
Ameritas Investment Partners first reported a position in COLL in Q1 2017 and has held it in 37 quarters since. The position peaked at $133K in Q1 2024. 266 funds tracked by Wall St. Rank hold COLL as of Q1 2026.
- Ameritas Investment Partners held 2,677 shares of Collegium Pharmaceutical worth $88.5K as of Q1 2026.
- Ameritas Investment Partners left its Collegium Pharmaceutical share count unchanged in Q1 2026.
- Collegium Pharmaceutical made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #1758 holding.
- Ameritas Investment Partners first reported a position in Collegium Pharmaceutical in Q1 2017 and has held it in 37 quarters since.
- Ameritas Investment Partners's Collegium Pharmaceutical position peaked at $133K in Q1 2024.
- 266 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.
Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.